{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicz4tcumfintk5gjciv32ll55immmqrn4vvyc7sewniol7pwipnry",
    "uri": "at://did:plc:izotgtw5czjnuqtpcldjnkjh/app.bsky.feed.post/3mof2yod7q3p2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicrnl3xxhfwgheiiwhdw7s4p2w4tgdc7xwa5q5janjwmexnokhckq"
    },
    "mimeType": "image/jpeg",
    "size": 95624
  },
  "path": "/popular-weight-loss-drugs-like-ozempic-linked-to-lower-breast-cancer-risk/",
  "publishedAt": "2026-06-15T10:34:11.000Z",
  "site": "https://scitechdaily.com",
  "tags": [
    "Health",
    "Breast Cancer",
    "Semaglutide",
    "University of Pennsylvania"
  ],
  "textContent": "Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight. A large new study found that women taking these [...]",
  "title": "Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk"
}